Sanofi SNY Archived

-5.89%
Discovered (Elapsed 333days) Discovery price $48.18 Current price $45.34 Price updated

This entry is more than 3 months old and has been archived. Prices reflect the last update.

✅ Key Summary

Sanofi is a global biopharmaceutical company focused on human health. Recently, the company reported strong quarterly results driven by its diverse product portfolio. Despite market fluctuations, its valuation remains attractive.

Advertisement

🏢 Company Overview

Sanofi, a leading biopharmaceutical company, specializes in developing therapies for various health conditions, including diabetes, oncology, and vaccines. In its latest quarterly report, the company demonstrated robust revenue growth, primarily fueled by strong sales of its immunology and specialty care products. The company’s diverse portfolio helps mitigate risks associated with market volatility. Currently, the stock is trading at $48.18, reflecting a market capitalization of approximately $117.6 billion. Analysts note that its valuation metrics indicate potential upside, considering the internal basis point deviation of 196389. Overall, Sanofi's strategic initiatives and solid fundamentals position it well in the competitive pharmaceutical landscape.

📰 Related News

  • Sanofi Announces Positive Results from Clinical Trials
    Positive news may boost investor confidence.
  • FDA Approves New Diabetes Drug by Sanofi
    Approval could significantly enhance revenue streams.

🏭 Competitor Comparison

  • Pfizer PFE
    A major player with a strong vaccine portfolio.
  • Novartis NVS
    Competes in similar therapeutic areas with a diverse pipeline.

📅 Sanofi discovery history

This stock has been discovered 7 times.

DiscoveredDiscovery priceCurrent priceReturn
Oct 22, 2026 $41.96 $48.37 +15.28%
Aug 17, 2026 $44.41 $48.37 +8.92%
Jun 29, 2026 $43.43 $42.48 -2.19%
May 8, 2026 $43.31 $42.89 -0.97%
Mar 26, 2026 $46.62 $41.33 -11.35%
Jan 9, 2026 $49.03 $47.14 -3.85%
Go to the Sanofi ticker page →
Advertisement

Other recent discoveries

← Back to list